Ruixia Cui

1.8k total citations · 1 hit paper
26 papers, 1.3k citations indexed

About

Ruixia Cui is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Ruixia Cui has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Epidemiology and 8 papers in Hepatology. Recurrent topics in Ruixia Cui's work include Liver Disease Diagnosis and Treatment (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Inflammasome and immune disorders (4 papers). Ruixia Cui is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Inflammasome and immune disorders (4 papers). Ruixia Cui collaborates with scholars based in China and United Kingdom. Ruixia Cui's co-authors include Jingyao Zhang, Kai Qu, Risheng Wang, Hongying Meng, Asoke K. Nandi, Tao Lei, Bingtao Zhang, Yifan Jia, Yang Feng and Yingmu Tong and has published in prestigious journals such as Oncotarget, Frontiers in Pharmacology and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Ruixia Cui

26 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Medical image segmentation using deep learning: A survey

2022 406 citations Risheng Wang, Tao Lei et al. IET Image Processing profile →

Peers

Countries citing papers authored by Ruixia Cui

Since Specialization

Citations

This map shows the geographic impact of Ruixia Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruixia Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruixia Cui more than expected).

Fields of papers citing papers by Ruixia Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruixia Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruixia Cui. The network helps show where Ruixia Cui may publish in the future.

Co-authorship network of co-authors of Ruixia Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Ruixia Cui. A scholar is included among the top collaborators of Ruixia Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruixia Cui. Ruixia Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Uncovering critical transitions and molecule mechanisms in disease progressions using Gaussian graphical optimal transport 2025 ·Communications Biology ·(unknown), Ruixia Cui, Heran Yang, Jingyao Zhang, Chang Liu, Jian Sun	1
2	NEDD4 lactylation promotes APAP induced liver injury through Caspase11 dependent non-canonical pyroptosis 2024 ·International Journal of Biological Sciences ·Qinglin Li, (unknown), Hai Wang, Yingmu Tong, Yunong Fu, (unknown), (unknown), Cong Wang, Zi Wang, Yifan Jia, Rui Chen, (unknown), Ruixia Cui, Yi Wu, (unknown), Kai Qu, Chang Liu, Jingyao Zhang	31
3	Association between sarcopenia and new-onset chronic kidney disease among middle-aged and elder adults: findings from the China Health and Retirement Longitudinal Study 2024 ·BMC Geriatrics ·Ying Liu, Yang Wu, (unknown), Kun Yang, Yingmu Tong, (unknown), Cong Wang, Ruixia Cui, Jie Ren, Qinglin Li, Hai Wang, Chang Liu, Jingyao Zhang	7
4	NSAID Treatment Before and on the Early Onset of Acute Kidney Injury Had an Opposite Effect on the Outcome of Patients With AKI 2022 ·Frontiers in Pharmacology ·Hai Wang, Tong Liu, Qinglin Li, Ruixia Cui, Xueying Fan, Yingmu Tong, (unknown), (unknown), Jingyao Zhang	3
5	PPARγ Alleviates Sepsis‐Induced Liver Injury by Inhibiting Hepatocyte Pyroptosis via Inhibition of the ROS/TXNIP/NLRP3 Signaling Pathway 2022 ·Oxidative Medicine and Cellular Longevity ·Zeyu Li, Tong Liu, Yang Feng, Yingmu Tong, Yifan Jia, Cong Wang, Ruixia Cui, Kai Qu, Chang Liu, Jingyao Zhang	46
6	Medical image segmentation using deep learning: A survey breakdown → 2022 ·IET Image Processing ·Risheng Wang, Tao Lei, Ruixia Cui, Bingtao Zhang, Hongying Meng, Asoke K. Nandi	406
7	An Interpretable Early Dynamic Sequential Predictor for Sepsis-Induced Coagulopathy Progression in the Real-World Using Machine Learning 2021 ·Frontiers in Medicine ·Ruixia Cui, (unknown), Kai Qu, Heran Yang, Yingmu Tong, Qinglin Li, Hai Wang, Yanfen Ma, (unknown), Ting Lin, Jingyao Zhang, Jian Sun, Chang Liu	4
8	Development of an Early Warning Model for Predicting the Death Risk of Coronavirus Disease 2019 Based on Data Immediately Available on Admission 2021 ·Frontiers in Medicine ·Hai Wang, (unknown), Yunong Fu, Qinglin Li, Ruixia Cui, Xiaohua Ma, Yanfen Ma, Zi Wang, Tong Liu, (unknown), Kai Qu, Chang Liu, Jingyao Zhang	7
9	Metformin protects against intestinal ischemia-reperfusion injury and cell pyroptosis via TXNIP-NLRP3-GSDMD pathway 2020 ·Redox Biology ·Yifan Jia, Ruixia Cui, Cong Wang, Yang Feng, Zeyu Li, Yingmu Tong, Kai Qu, Chang Liu, Jingyao Zhang	249
10	Comparison of survival between adolescent and young adult vs older patients with hepatocellular carcinoma 2020 ·World Journal of Gastrointestinal Oncology ·Jie Ren, Yingmu Tong, Ruixia Cui, Zi Wang, Qinglin Li, Wei Liu, Kai Qu, Jingyao Zhang, Chang Liu, Yong Wan	6
11	Simplified nomograms based on platelet-associated models for survival prediction in Asian hepatocellular carcinoma patients after surgery 2019 ·Surgical Oncology ·Jingxian Gu, Xing Zhang, Zhixin Wang, Ruixia Cui, (unknown), Yifan Jia, Runchen Miao, Haining Fan, Haijiu Wang, Yiming Li, Jingyao Zhang, Chang Liu, Kai Qu	5
12	Methane Alleviates Acetaminophen-Induced Liver Injury by Inhibiting Inflammation, Oxidative Stress, Endoplasmic Reticulum Stress, and Apoptosis through the Nrf2/HO-1/NQO1 Signaling Pathway 2019 ·Oxidative Medicine and Cellular Longevity ·Yang Feng, Ruixia Cui, Zeyu Li, Xia Zhang, Yifan Jia, Xing Zhang, (unknown), Kai Qu, Chang Liu, Jingyao Zhang	86
13	Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization 2019 ·European Journal of Gastroenterology & Hepatology ·Jingxian Gu, Xing Zhang, Ruixia Cui, Jia Zhang, Zhixin Wang, Yifan Jia, Runchen Miao, Yanyan Dong, Xiaohua Ma, Haining Fan, Haijiu Wang, Li Ren, Yiming Li, Wenquan Niu, Jingyao Zhang, Kai Qu, Chang Liu	14
14	Methane-Rich Saline Counteracts Cholestasis-Induced Liver Damage via Regulating the TLR4/NF-κB/NLRP3 Inflammasome Pathway 2019 ·Oxidative Medicine and Cellular Longevity ·Zeyu Li, Dongdong Chen, Yifan Jia, Yang Feng, Cong Wang, Yingmu Tong, Ruixia Cui, Kai Qu, Chang Liu, Jingyao Zhang	34
15	Simvastatin protects against acetaminophen-induced liver injury in mice 2018 ·Biomedicine & Pharmacotherapy ·Huan Liang, Yang Feng, Ruixia Cui, (unknown), Jingyao Zhang, Chang Liu	18
16	Methane‐Rich Saline Ameliorates Sepsis‐Induced Acute Kidney Injury through Anti‐Inflammation, Antioxidative, and Antiapoptosis Effects by Regulating Endoplasmic Reticulum Stress 2018 ·Oxidative Medicine and Cellular Longevity ·Yifan Jia, Zeyu Li, Yang Feng, Ruixia Cui, Yanyan Dong, Xing Zhang, Xiaohong Xiang, Kai Qu, Chang Liu, Jingyao Zhang	49
17	Identification of Four Oxidative Stress‐Responsive MicroRNAs, miR‐34a‐5p, miR‐1915‐3p, miR‐638, and miR‐150‐3p, in Hepatocellular Carcinoma 2017 ·Oxidative Medicine and Cellular Longevity ·Yong Wan, Ruixia Cui, Jingxian Gu, Xing Zhang, Xiaohong Xiang, Chang Liu, Kai Qu, Ting Lin	58
18	Astaxanthin alleviated acute lung injury by inhibiting oxidative/nitrative stress and the inflammatory response in mice 2017 ·Biomedicine & Pharmacotherapy ·Jianbin Bi, Ruixia Cui, Zeyu Li, Chang Liu, Jingyao Zhang	44
19	Validation of inflammation-based prognostic models in patients with hepatitis B-associated hepatocellular carcinoma: a retrospective observational study 2017 ·European Journal of Gastroenterology & Hepatology ·Qing Pang, Lei Zhou, Kai Qu, Ruixia Cui, Hao Jin, Huichun Liu	22
20	Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis? 2016 ·Oncotarget ·Kai Qu, Tian Liu, Ting Lin, Xing Zhang, Ruixia Cui, Sinan Liu, Fandi Meng, Jingyao Zhang, Ming‐Hui Tai, Yong Wan, Chang Liu	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact